38 related articles for article (PubMed ID: 36367018)
1. SPCS, a Novel Classifier System Based on Senescence Axis Regulators Reveals Tumor Microenvironment Heterogeneity and Guides Frontline Therapy for Clear Cell Renal Carcinoma.
Jiang A; Liu Y; Zhu B; Fang Y; Qu L; Yang Q; Luo P; Cai C; Wang L
Clin Genitourin Cancer; 2024 Apr; 22(2):497-513. PubMed ID: 38245436
[TBL] [Abstract][Full Text] [Related]
2. Identification of Treg-related prognostic molecular subtypes and individualized characteristics in clear cell renal cell carcinoma through single-cell transcriptomes and bulk RNA sequencing.
Weng KQ; Liu JY; Li H; She LL; Qiu JL; Qi H; Qi HY; Li YS; Dai YB
Int Immunopharmacol; 2024 Mar; 130():111746. PubMed ID: 38442575
[TBL] [Abstract][Full Text] [Related]
3. Renal enhanced CT images reveal the tandem mechanism between tumor cells and immunocytes based on bulk/single-cell RNA sequencing.
Liang H; Wu K; Wu R; Huang K; Deng Z; Chen H
Funct Integr Genomics; 2023 Mar; 23(2):88. PubMed ID: 36933049
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of disulfidptosis-related genes: a prognosis model construction and tumor microenvironment characterization in clear cell renal cell carcinoma.
Yi B; Wei X; Liu D; Jing L; Xu S; Zhang M; Liang Z; Liu R; Zhang Z
Aging (Albany NY); 2024 Feb; 16(4):3647-3673. PubMed ID: 38358909
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Molecular Heterogeneity Associated With Tumor Microenvironment in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy.
Zhong W; Li Y; Yuan Y; Zhong H; Huang C; Huang J; Lin Y; Huang J
Front Cell Dev Biol; 2021; 9():736540. PubMed ID: 34631713
[TBL] [Abstract][Full Text] [Related]
6. Cellular senescence and metabolic reprogramming model based on bulk/single-cell RNA sequencing reveals PTGER4 as a therapeutic target for ccRCC.
Zhou L; Zeng Y; Liu Y; Du K; Luo Y; Dai Y; Pan W; Zhang L; Zhang L; Tian F; Gu C
BMC Cancer; 2024 Apr; 24(1):451. PubMed ID: 38605343
[TBL] [Abstract][Full Text] [Related]
7. The vasculogenic mimicry related signature predicts the prognosis and immunotherapy response in renal clear cell carcinoma.
Gu Y; Huang Q; Wang Y; Wang H; Xiang Z; Xu Y; Wang X; Liu W; Wang A
BMC Cancer; 2024 Apr; 24(1):420. PubMed ID: 38580922
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a G2M checkpoint-related gene model and subtypes associated with immunotherapy response for clear cell renal cell carcinoma.
Wang Z; Zheng Z; Wang B; Zhan C; Yuan X; Lin X; Xin Q; Zhong Z; Qiu X
Heliyon; 2024 Apr; 10(7):e29289. PubMed ID: 38617927
[TBL] [Abstract][Full Text] [Related]
9. Identification of clear cell renal cell carcinoma subtypes by integrating radiomics and transcriptomics.
Gao R; Pang J; Lin P; Wen R; Wen D; Liang Y; Ma Z; Liang L; He Y; Yang H
Heliyon; 2024 Jun; 10(11):e31816. PubMed ID: 38841440
[TBL] [Abstract][Full Text] [Related]
10. Multiomics characterization and verification of clear cell renal cell carcinoma molecular subtypes to guide precise chemotherapy and immunotherapy.
Meng J; Jiang A; Lu X; Gu D; Ge Q; Bai S; Zhou Y; Zhou J; Hao Z; Yan F; Wang L; Wang H; Du J; Liang C
Imeta; 2023 Nov; 2(4):e147. PubMed ID: 38868222
[TBL] [Abstract][Full Text] [Related]
11. 2022 WUOF/SIU International Consultation on Urological Diseases: Genetics and Tumor Microenvironment of Renal Cell Carcinoma.
Khaleel S; Ricketts C; Linehan WM; Ball M; Manley B; Turajilic S; Brugarolas J; Hakimi A
Soc Int Urol J; 2022 Nov; 3(6):386-396. PubMed ID: 38840811
[TBL] [Abstract][Full Text] [Related]
12. Patient Stratification of Clear Cell Renal Cell Carcinoma Using the Global Transcription Factor Activity Landscape Derived From RNA-Seq Data.
Zhu Y; Cang S; Chen B; Gu Y; Jiang M; Yan J; Shao F; Huang X
Front Oncol; 2020; 10():526577. PubMed ID: 33344220
[TBL] [Abstract][Full Text] [Related]
13. Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes.
Haukaas TH; Euceda LR; Giskeødegård GF; Lamichhane S; Krohn M; Jernström S; Aure MR; Lingjærde OC; Schlichting E; Garred Ø; Due EU; Mills GB; Sahlberg KK; Børresen-Dale AL; Bathen TF;
Cancer Metab; 2016; 4():12. PubMed ID: 27350877
[TBL] [Abstract][Full Text] [Related]
14. Histopathology Based AI Model Predicts Anti-Angiogenic Therapy Response in Renal Cancer Clinical Trial.
Jasti J; Zhong H; Panwar V; Jarmale V; Miyata J; Carrillo D; Christie A; Rakheja D; Modrusan Z; Kadel EE; Beig N; Huseni M; Brugarolas J; Kapur P; Rajaram S
ArXiv; 2024 May; ():. PubMed ID: 38855551
[TBL] [Abstract][Full Text] [Related]
15. A novel basement membrane-related gene signature for prognosis of lung adenocarcinomas.
Zhang Z; Zhu H; Wang X; Lin S; Ruan C; Wang Q
Comput Biol Med; 2023 Mar; 154():106597. PubMed ID: 36708655
[TBL] [Abstract][Full Text] [Related]
16. Integrated analyses reveal the prognostic, immunological features and mechanisms of cuproptosis critical mediator gene FDX1 in KIRC.
Wang Y; Zhang X; Chen G; Xing Q; Zhu B; Wang X
Genes Immun; 2023 Aug; 24(4):171-182. PubMed ID: 37430022
[TBL] [Abstract][Full Text] [Related]
17. Molecular subtypes based on metabolic genes are potential biomarkers for predicting prognosis and immune responses of clear cell renal cell carcinoma.
Wang Y; Ji H; Zhu B; Xing Q; Xie H
Eur J Immunol; 2023 Jan; 53(1):e2250105. PubMed ID: 36367018
[TBL] [Abstract][Full Text] [Related]
18. Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis.
Yue Y; Cai X; Lu C; Sechi LA; Solla P; Li S
Front Immunol; 2023; 14():1238312. PubMed ID: 37908350
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of cellular senescence-related genes in the prognosis, tumor microenvironment, and immunotherapy/chemotherapy of clear cell renal cell carcinoma.
Lu C; Wang Y; Nie L; Chen L; Li M; Qing H; Li S; Wu S; Wang Z
Front Immunol; 2022; 13():934243. PubMed ID: 36189255
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
